TAVI is the gold standard for symptomatic severe aortic stenosis at elevated surgical risk, but procedural complications and unmet needs in specific anatomical subsets remain.
Answers are grounded in this paper and cite their sources.
Prioritizes device innovation to mitigate TAVI complications; leaves open targeted strategies for complex anatomical subsets.
Transcatheter aortic valve implantation (TAVI) has emerged as the gold standard technique for all patients with symptomatic severe aortic stenosis at elevated surgical risk. Much progress has been made to reduce procedural complications and improve patient outcomes. The impressive results of contemporary TAVI can be attributed to a variety of factors, including improving operator experience, pre-operative patient screening, and developments in transcatheter heart valve and delivery system technology. Despite these advances, serious procedural complications continue to occur and there remain some anatomical subsets and patient groups to whom TAVI technology has not been expanded. Herein we discuss these unmet needs in TAVI.
No takes yet. Share an insight, caveat, or question.
Neylon et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: